查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1883721

细胞治疗培养基市场：产业趋势及全球预测（至 2035 年）－依产品类型、细胞治疗类型、企业规模、终端使用者类型及地区划分

Cell Therapy Media Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Product, Type of Cell Therapy, Scale of Operation, Type of End User and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

细胞治疗培养基市场：概述

根据 Roots Analysis 的研究，全球细胞治疗培养基市场预计将从目前的 16 亿美元增长到 2035 年的 45 亿美元，在预测期内（截至 2035 年）的复合年增长率 (CAGR) 为 11.1%。

市场规模和机会分析基于以下参数进行区隔：

产品类型

  • 培养基及试剂盒
  • 细胞培养试剂
  • 细胞外基质

细胞疗法类型

  • T细胞疗法
  • 干细胞疗法
  • 树突细胞疗法
  • NK细胞疗法

业务规模

  • 临床
  • 商业

内皮细胞疗法使用者类型

  • 行业
  • 非工业

主要地区

  • 北美
  • 欧洲
  • 亚太地区
  • 中东和北非
  • 拉丁美洲美国

细胞治疗培养基市场：成长与趋势

由于FDA批准的细胞疗法在癌症、罕见疾病和慢性病治疗方面取得了显着进展并证实了其疗效，因此细胞治疗培养基市场已引起医疗保健行业利益相关者的广泛关注。值得注意的是，自2019年以来，已有超过1,000项临床试验註册，其中大部分专注于细胞疗法。此外，全球各地已推出超过35种细胞和基因疗法。近期核准的细胞疗法包括Breyanzi®、Carvykti™和Abecma®。

由于细胞治疗耗材的生产监管日益严格，该领域超过90%的研发企业选择将培养基、试剂盒、试剂和细胞外基质外包给具备提供高品质原料专业知识的供应商。目前，超过 80 家公司提供 450 多种科学研究级和/或治疗级原料。此外，一些公司声称拥有符合 GMP 标准的设施，用于生产各种人类细胞类型（包括 T 细胞、干细胞、树突状细胞和 NK 细胞）的耗材。

随着细胞疗法的不断发展，预计该行业将涌现更多创新和合作，从而催生新的治疗方案，这些方案有望彻底改变患者护理，并拓展再生医学的应用范围。

细胞治疗培养基市场：关键洞察

本报告深入分析了细胞治疗培养基市场的现状，并指出了该行业的潜在成长机会。主要发现包括：

凭藉其专业知识，耗材供应商生产 450 多种用于科研和治疗的试剂盒、培养基、试剂和细胞外基质。

2.全球有超过 80 家公司活跃于该市场，其中大多数是总部位于北美的新创公司。

3. 细胞治疗领域现有的大多数试剂盒包含各种试剂，其中 60% 用于干细胞治疗，约 80% 需要冷藏保存。

细胞治疗培养基市场-IMG1

4. 培养基开发商提供各种细胞治疗产品，其中约 90% 的公司提供的培养基容量范围为 100-500ml。

5. 细胞治疗试剂主要用于发现阶段和规模化生产，可用于多种功能，包括细胞生长和扩增。

6. 细胞治疗基质的市场格局较为均衡，其保存期限通常为 1-1.5 年，涵盖各种 ECM 涂层类型和配方。

7. 为了获得竞争优势，细胞治疗耗材供应商正在不断改进现有技术并拓展产品组合。

8. 许多公司正在采取策略性举措，例如建立合作伙伴关係、进行收购和业务扩张，以增强其现有能力。

9. 预计产业利害关係人将继续与该领域的区隔/专业公司建立策略联盟，以进一步扩展其产品线。

10. 多年来，行业利益相关者透过各种举措建立了强大的品牌地位，以进一步推进细胞治疗原材料的开发。

11. 成本是细胞治疗生产过程中耗材应用的关键因素。

12. 预计到 2035 年，商业规模的运作将占细胞治疗耗材总需求的 75%。这主要归因于多种细胞疗法获批数量的预期快速增长。

细胞治疗培养基市场-IMG2

13. 从动物性配方转变为非动物性配方的典范转移，加上严格的监管指南，预计将推动细胞治疗耗材市场以 11.1% 的年增长率成长。

细胞治疗培养基市场：主要区隔市场

细胞治疗培养基市场中成长最快的区隔市场是细胞外基质。

依产品类型划分，市场可分为培养基、试剂盒、细胞培养试剂及细胞外基质。值得注意的是，培养基目前占细胞治疗培养基市场的大部分。

预计在预测期内，T细胞疗法将主导细胞治疗培养基市场。

依细胞疗法类型划分，市场可分为T细胞疗法、干细胞疗法、树突细胞疗法和NK细胞疗法。值得注意的是，NK细胞疗法的细胞治疗耗材市场预计在预测期内将以相对较高的复合年增长率成长。这是因为目前有超过75项针对NK细胞疗法治疗各种疾病的临床研究正在进行评估。预计未来几年这一数字将进一步成长，从而可能推动这些疗法的市场发展。

依企业规模划分，商业规模预计将在预测期内推动细胞治疗培养基市场的发展。

依企业规模，市场分为临床规模与商业规模。值得注意的是，商业规模的细胞治疗培养基市场在不久的将来可能会成为市场的主要推动力。

工业企业占细胞治疗培养基市场的最大占有率。

根据最终用户类型，市场分为工业用户和非工业用户。值得注意的是，工业用户导向的细胞治疗培养基市场在不久的将来可能会成为市场的主要推动力。这是因为工业企业对整体商业市场贡献巨大，大多数核准疗法都是由这些企业开发的。

北美占最大的市占率。

依主要地区划分，市场分为北美、欧洲、亚太、中东和北非以及拉丁美洲。值得注意的是，预计未来几年拉丁美洲市场的复合年增长率将更高。

细胞治疗培养基市场代表性公司

  • BD Biosciences
  • Bio-Techne
  • CellGenix
  • Corning
  • Irvine Scientific（已被富士软片收购）
  • Lonza
  • Miltenyi Biotech
  • Sartorius
  • STEMCELL Technologies
  • Thermo Fisher Scientific

主要研究概述

本研究中提出的观点和见解是基于与多位利害关係人的讨论。本研究报告包含以下产业参与者的详细访谈记录：

  • A公司业务发展副总裁
  • B公司营运长 (COO)
  • C公司细胞培养与免疫学研发总监
  • D公司动物细胞培养研发助理经理

目录

第一章：前言

第二章：摘要整理

第三章：导论

  • 背景介绍
  • 细胞疗法简介
  • 细胞疗法与其他生物製药的比较
  • 细胞疗法产品分类
  • 细胞疗法开发与生产概述
  • 原料在细胞疗法开发与生产中的作用
  • 类型细胞治疗耗材
  • 细胞治疗耗材生产面临的主要挑战
  • 未来展望

第四章 市场概览

  • 章节概述
  • 细胞治疗试剂盒供应商列表
  • 细胞治疗培养基供应商列表
  • 细胞治疗试剂供应商列表
  • 细胞治疗细胞外基质供应商列表

第五章：竞争分析

  • 章节概述
  • 关键假设与参数
  • 研究方法
  • 细胞治疗耗材供应商：竞争分析
  • 细胞治疗试剂盒供应商
  • 细胞治疗培养基供应商
    • 北美细胞治疗培养基供应商
    • 欧洲细胞治疗培养基供应商供应商
    • 亚太地区细胞治疗培养基供应商
  • 细胞治疗试剂供应商
  • 细胞治疗细胞外基质供应商

第六章：主要产业参与者的品牌定位

第七章 公司简介

  • 章节概述
  • STEMCELL Technologies
  • Miltenyi Biotec
  • Thermo Fisher Scientific
  • Bio-Techne
  • Irvine Scientific
  • Lonza
  • Sartorius
  • BD Biosciences
  • Corning
  • CellGenix

第八章：近期趋势与举措

  • 章节概述
  • 合作模式
  • 细胞治疗耗材：合作与协作
  • 细胞治疗耗材：併购
  • 细胞治疗耗材：近期扩张

第九章：细胞治疗耗材供应商的理想伙伴分析

  • 章节概述
  • 评分标准与关键假设
  • 研究范围与方法
  • 细胞治疗耗材供应商的关键潜在策略伙伴

第十章：ROOTS 分析定价策略

  • 章节概述
  • ROOTS 分析定价策略框架

第十一章：需求分析

第十二章：市场预测与机会分析

  • 章节概述
  • 关键假设与研究方法
  • 2035 年全球细胞治疗耗材市场
  • 细胞治疗耗材市场：依产品类型分析
  • 细胞治疗耗材市场：依细胞治疗类型分析
  • 细胞治疗耗材市场：依企业规模分析
  • 细胞治疗耗材市场：依终端使用者类型分析
  • 细胞治疗耗材市场：依地区分析

第十三章：未来趋势与成长机会

  • 章节概述
  • 细胞培养基的新兴趋势
  • 细胞治疗生产流程的自动化
  • 细胞治疗生产中的一次性系统和技术

第十四章：结论

第十五章：访谈记录

第十六章：附录一：表格数据

第十七章，附录二：公司与组织列表

Product Code: RA100418

CELL THERAPY MEDIA MARKET: OVERVIEW

As per Roots Analysis, the global cell therapy media market is estimated to grow from USD 1.6 billion in the current year to USD 4.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Product

  • Culture Media, Kits
  • Cell Culture Reagents
  • Extracellular Matrices

Type of Cell Therapy

  • T-Cell Therapy
  • Stem Cell Therapy
  • Dendritic Cell Therapy
  • NK Cell Therapy

Scale of Operation

  • Clinical
  • Commercial

Type of End User

  • Industry
  • Non-Industry

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

CELL THERAPY MEDIA MARKET: GROWTH AND TRENDS

Fueled by significant advancements and the established efficacy of FDA-approved cell therapies for treating cancer, rare diseases, and chronic conditions, the cell therapy media market has garnered significant interest from stakeholders in the healthcare sector. Interestingly, over 1,000 clinical trials primarily focused on cell therapies have been registered since 2019. Further, more than 35 cell and gene therapies have been brought to market in different regions around the world. Recent cell therapy approval includes Breyanzi(R), Carvykti(TM), and Abecma(R).

With rising regulatory stringency associated with producing consumables for cell therapy, more than 90% of developers in this field opt to outsource culture media, kits, reagents, and extracellular matrices to suppliers with the required expertise to provide high-quality raw materials. Currently, over 80 companies are providing more than 450 research and / or therapeutic grade raw materials. Moreover, certain companies claim to have GMP-certified facilities for manufacturing consumables intended for various human cells, such as T-cells, stem cells, dendritic cells, and NK cells.

With the ongoing evolution of cell therapy, we expect a rise in innovation and partnerships in the industry, leading to new therapeutic alternatives with the potential to revolutionize patient care and broaden the scope of regenerative medicine.

CELL THERAPY MEDIA MARKET: KEY INSIGHTS

The report delves into the current state of the cell therapy media market and identifies potential growth opportunities within the industry. Some key findings from the report include:

1. Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes.

2. The market features the presence of over 80 firms across the globe; the majority of these stakeholders are emerging players based in North America.

3. A larger proportion of the kits available in the cell therapy domain comprises different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions.

Cell Therapy Media Market - IMG1

4. Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml.

5. Predominantly, the cell therapy reagents are intended to be used at the discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation.

6. The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation.

7. In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios.

8. Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities.

9. We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings.

10. Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies.

11. Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process.

12. In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy consumables; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies.

Cell Therapy Media Market - IMG2

13. A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy consumables market at an annualized rate of 11.1%.

CELL THERAPY MEDIA MARKET: KEY SEGMENTS

Extracellular Matrices is the Fastest Growing Segment in the Cell Therapy Media Market

Based on the type of product, the market is segmented into culture media, kits, cell culture reagents and extracellular matrices. It is worth highlighting that majority of the current cell therapy media market is captured by culture media.

T-Cell Therapy is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the type of cell therapy, the market is segmented into T-Cell therapy, stem cell therapy, dendritic cell therapy and NK cell therapy. It is worth highlighting that the cell therapy consumables market for NK cell therapies is likely to grow at a relatively higher CAGR, during the forecast period. This can be attributed to the fact that currently, more than 75 NK cell therapy focused clinical studies are being evaluated for a myriad of disease indications. In the coming years, this number is anticipated to increase further, and this is likely to boost the market opportunity for such therapies.

By Scale of Operation, Commercial Scale is Likely to Dominate the Cell Therapy Media Market During the Forecast Period

Based on the scale of operation, the market is segmented into clinical and commercial scales. It is worth highlighting that the commercial scale cell therapy media market is likely to drive the market in the near future.

Industry Players Segment Accounts for the Largest Share of the Cell Therapy Media Market

Based on the type of end user, the market is segmented into industry and non-industry. It is worth highlighting that the cell therapy media market for industry players is likely to drive the market in the near future. This can be attributed to the fact that the industry players contribute significantly to the overall commercial market as majority of the approved therapies have been developed by such players.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth highlighting that, over the years, the market in Latin America is expected to grow at a higher CAGR.

Example Players in the Cell Therapy Media Market

  • BD Biosciences
  • Bio-Techne
  • CellGenix
  • Corning
  • Irvine Scientific (Acquired by FUJIFILM)
  • Lonza
  • Miltenyi Biotech
  • Sartorius
  • STEMCELL Technologies
  • Thermo Fisher Scientific

Primary Research Overview

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:

  • Vice President of Business Development, Company A
  • Chief Operating Officer, Company B
  • Director R&D, Cell Culture and Immunology, Company C
  • Assistant R&D Manager, Animal Cell Culture, Company D

CELL THERAPY MEDIA MARKET: RESEARCH COVERAGE

  • Market Forecast and Opportunity Analysis: The report features an in-depth analysis of the cell therapy media market, focusing on key market segments, including [A] type of product, [B] type of cell therapy, [C] scale of operation, [D] type of end user and [E] key geographical regions.
  • Market Landscape: A comprehensive evaluation of companies offering cell culture consumables and cell culture media, considering various parameters, [A] such as year of establishment, [B] company size (in terms of number of employees), [C] location of headquarters, [D] type of product, [E] number and location of consumable facilities, [F] accreditations received, [G] type of end-user, [H] cell culture media compatibility, [I] type of cell therapy, [J] type of function, [K] kit components, [L] type of ECM coating, [M] type of formulation, [N] shelf life, [O] scale of operation, [P] application area, and [Q] storage temperature.
  • Company Competitiveness Analysis: A comprehensive competitive analysis of companies operating in the cell culture consumable and cell culture media market, examining factors such as [A] supplier strength, [B] portfolio strength and [C] number of products offered.
  • Brand Positioning Analysis: A detailed brand positioning analysis of prominent industry players, highlighting the current perceptions regarding their proprietary brands across different consumable classes.
  • Company Profiles: In-depth profiles of key industry players in cell therapy consumables and cell culture media market, focusing on [A] company overviews, [B] product portfolio, [C] consumable facilities, [D] recent developments and an [E] informed future outlook.
  • Recent Developments and Initiatives: An analysis of recent developments within the cell culture consumables and cell culture media market, [A] covering partnerships and collaborations, [B] mergers and acquisitions, and [B] expansion initiatives.
  • Likely Partner Analysis: A detailed evaluation of over 250 cell therapy developers that are most likely to collaborate with cell culture consumables and cell culture media providers. This analysis considers various relevant parameters, including [A] developer strength (which takes into account a company's size and its experience in this field), [B] pipeline strength and [C] maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
  • Roots Analysis Pricing Strategy: A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in cell culture consumables and cell culture media market, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices).
  • Demand Analysis: Informed estimates of the annual demand for cell culture consumables and cell culture media (in terms of volume of media required for total number of cells), based on [A] scale of operation and [B] key geographical regions.
  • Upcoming Trends And Future Growth Opportunities: A comprehensive analysis of emerging trends and future growth prospects in the cell culture consumables and media market. It includes details related to the significance of automation in cell therapy manufacturing processes and the benefits of single use technologies for the production of cell therapies.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • What are the factors driving the cell therapy consumables market?
  • How many players are engaged in offering cell culture media for manufacturing cell therapies?
  • How many players are engaged in offering kits for manufacturing cell therapies?
  • How many media products are available in the market for culturing cell therapies?
  • What are the partnership and collaboration trends observed in the cell therapy consumables domain?
  • Which geographical segment captures the largest market share in the current cell therapy consumables market?
  • Which type of product contributes to the largest share of the cell therapy consumables market?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Context and Background
  • 3.2. Introduction to Cell Therapies
  • 3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
  • 3.4. Classification of Cell Therapy Products
  • 3.5. Overview of Cell Therapy Development and Manufacturing
  • 3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
  • 3.7. Types of Cell Therapy Consumables
  • 3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
  • 3.9. Future Perspectives

4. MARKET OVERVIEW

  • 4.1. Chapter Overview
  • 4.2. List of Cell Therapy Kit Providers
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Location of Kits Manufacturing Facilities
    • 4.2.5. Analysis by Certifications / Accreditations Received
    • 4.2.6. Analysis by Type of End-User
    • 4.2.7. Analysis by Type of Cell Therapy
    • 4.2.8. Analysis by Type of Function
    • 4.2.9. Analysis by Kit Components
    • 4.2.10. Analysis by Storage Temperature
    • 4.2.11. Analysis by Scale of Operation
    • 4.2.12. Analysis by Application Area
    • 4.2.13. Analysis by Application Area and Geography
  • 4.3. List of Cell Therapy Media Providers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Analysis by Location of Media Manufacturing Facilities
    • 4.3.5. Analysis by Certifications / Accreditations Received
    • 4.3.6. Analysis by Type of End-User
    • 4.3.7. Analysis by Type of Cell Therapy
    • 4.3.8. Analysis by Media Compatibility
    • 4.3.9. Analysis by Type of Function
    • 4.3.10. Analysis by Storage Temperature
    • 4.3.11. Analysis by Volume of Media
    • 4.3.12. Analysis by Scale of Operation
    • 4.3.13. Analysis by Application Area
    • 4.3.14. Analysis by Application Area and Geography
  • 4.4. List of Cell Therapy Reagent Providers
    • 4.4.1. Analysis by Year of Establishment
    • 4.4.2. Analysis by Company Size
    • 4.4.3. Analysis by Location of Headquarters
    • 4.4.4. Analysis by Location of Reagent Manufacturing Facilities
    • 4.4.5. Analysis by Certifications / Accreditations Received
    • 4.4.6. Analysis by Type of End-User
    • 4.4.7. Analysis by Type of Cell Therapy
    • 4.4.8. Analysis by Type of Function
    • 4.4.9. Analysis by Storage Temperature
    • 4.4.10. Analysis by Volume of Reagent
    • 4.4.11. Analysis by Scale of Operation
    • 4.4.12. Analysis by Application Area
    • 4.4.13. Analysis by Application Area and Geography
  • 4.5. List of Cell Therapy Extracellular Matrix Providers
    • 4.5.1. Analysis by Year of Establishment
    • 4.5.2. Analysis by Company Size
    • 4.5.3. Analysis by Location of Headquarters
    • 4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
    • 4.5.5. Analysis by Certifications / Accreditations Received
    • 4.5.6. Analysis by Type of End-User
    • 4.5.7. Analysis by Type of Stem Cell Therapy
    • 4.5.8. Analysis by Type of Function
    • 4.5.9. Analysis by Type of ECM Coating
    • 4.5.10. Analysis by Type of Formulation
    • 4.5.11. Analysis by Shelf Life
    • 4.5.12. Analysis by Storage Temperature
    • 4.5.13. Analysis by Volume of Extracellular Matrix
    • 4.5.14. Analysis by Scale of Operation
    • 4.5.15. Analysis by Application Area
    • 4.5.16. Analysis by Application Area and Geography

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Key Assumptions and Parameters
  • 5.3. Methodology
  • 5.4. Cell Therapy Consumables Providers: Company Competitiveness Analysis
  • 5.5. Cell Therapy Kit Providers
  • 5.6. Cell Therapy Media Providers
    • 5.6.1. Cell Therapy Media Providers based in North America
    • 5.6.2. Cell Therapy Media Providers based in Europe
    • 5.6.3. Cell Therapy Media Providers based in Asia-Pacific
  • 5.7. Cell Therapy Reagent Providers
  • 5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS

  • 6.1. Chapter Overview
  • 6.2. Scope and Methodology
  • 6.3. Brand Positioning: STEMCELL Technologies
  • 6.4. Brand Positioning: Miltenyi Biotec
  • 6.5. Brand Positioning: Thermo Fisher Scientific
  • 6.6. Brand Positioning: Takara Bio
  • 6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. STEMCELL Technologies
    • 7.2.1. Company Overview
    • 7.2.2. Product Portfolio
    • 7.2.3. Recent Developments and Future Outlook
  • 7.3. Miltenyi Biotec
    • 7.3.1. Company Overview
    • 7.3.2. Product Portfolio
    • 7.3.3. Recent Developments and Future Outlook
  • 7.4. Thermo Fisher Scientific
    • 7.4.1. Company Overview
    • 7.4.2. Product Portfolio
    • 7.4.3. Recent Developments and Future Outlook
  • 7.5. Bio-Techne
    • 7.5.1. Company Overview
    • 7.5.2. Product Portfolio
    • 7.5.3. Recent Developments and Future Outlook
  • 7.6. Irvine Scientific
    • 7.6.1. Company Overview
    • 7.6.2. Product Portfolio
    • 7.6.3. Recent Developments and Future Outlook
  • 7.7. Lonza
    • 7.7.1. Company Overview
    • 7.7.2. Product Portfolio
    • 7.7.3. Recent Developments and Future Outlook
  • 7.8. Sartorius
    • 7.8.1. Company Overview
    • 7.8.2. Product Portfolio
    • 7.8.3. Recent Developments and Future Outlook
  • 7.9. BD Biosciences
    • 7.9.1. Company Overview
    • 7.9.2. Product Portfolio
    • 7.9.3. Recent Developments and Future Outlook
  • 7.10. Corning
    • 7.10.1. Company Overview
    • 7.10.2. Product Portfolio
    • 7.10.3. Recent Developments and Future Outlook
  • 7.11. CellGenix
    • 7.11.1. Company Overview
    • 7.11.2. Product Portfolio
    • 7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Cell Therapy Consumables: Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Type of Product
    • 8.3.5. Analysis by Type of Partnership and Type of Product
    • 8.3.6. Analysis by Type of Cell Therapy
    • 8.3.7. Analysis by Type of Product and Type of Cell Therapy
    • 8.3.8. Most Active Players: Analysis by Number of Partnerships
    • 8.3.9. Analysis by Region
      • 8.3.9.1. Intercontinental and Intracontinental Agreements
      • 8.3.9.2. Local and International Agreements
  • 8.4. Cell Therapy Consumables: Mergers and Acquisitions
    • 8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
    • 8.4.2. Analysis by Type of Agreement
    • 8.4.3. Analysis by Key Value Drivers
    • 8.4.4. Analysis by Year of Acquisition and Key Value Drivers
  • 8.5. Cell Therapy Consumables: Recent Expansions
    • 8.5.1. Analysis by Year of Expansion
    • 8.5.2. Analysis by Type of Expansion
    • 8.5.3. Analysis by Year and Type of Expansion
    • 8.5.4. Analysis by Type of Product
    • 8.5.5. Analysis by Type of Expansion and Type of Product
    • 8.5.6. Analysis by Area of Expansion
    • 8.5.7. Most Active Players: Analysis by Number of Expansions
    • 8.5.8. Analysis by Region
      • 8.5.8.1. Analysis by Location of Facility (Continent-wise)
      • 8.5.8.2. Analysis by Location of Facility (Country-wise)
    • 8.5.9. Analysis by Type of Expansion and Location of Facility

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS

  • 9.1. Chapter Overview
  • 9.2. Scoring Criteria and Key Assumptions
  • 9.3. Scope and Methodology
  • 9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
    • 9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
    • 9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
    • 9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
    • 9.4.4. Likely Partners for T-Cell Therapy Consumable Providers

10. ROOTS ANALYSIS PRICING STRATEGY

  • 10.1. Chapter Overview
  • 10.2. Roots Analysis Pricing Strategy Framework
    • 10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
      • 10.2.1.1. Methodology
      • 10.2.1.2. Results and Interpretation
        • 10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
        • 10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
        • 10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
        • 10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
        • 10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
        • 10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
        • 10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
    • 10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
      • 10.2.2.1. Methodology
      • 10.2.2.2. Results and Interpretation
        • 10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
        • 10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
        • 10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
        • 10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
        • 10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
        • 10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
        • 10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function

11. DEMAND ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Global Demand for Cell Therapy Consumables
    • 11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
    • 11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
  • 11.4. Analysis by Scale of Operation
  • 11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Cell Therapy Consumables Market, Till 2035
  • 12.4. Cell Therapy Consumables Market: Analysis by Type of Product
    • 12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, Till 2035
    • 12.4.2. Cell Therapy Consumables Market for Kits, Till 2035
    • 12.4.3. Cell Therapy Consumables Market for Media, Till 2035
    • 12.4.4. Cell Therapy Consumables Market for Reagents, Till 2035
  • 12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
    • 12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, Till 2035
    • 12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, Till 2035
    • 12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, Till 2035
    • 12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, Till 2035
  • 12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
    • 12.6.1. Cell Therapy Consumables Market for Clinical Operations, Till 2035
    • 12.6.2. Cell Therapy Consumables Market for Commercial Operations, Till 2035
  • 12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
    • 12.7.1. Cell Therapy Consumables Market for Industry Players, Till 2035
    • 12.7.2. Cell Therapy Consumables Market for Non-Industry Players, Till 2035
  • 12.8. Cell Therapy Consumables Market: Analysis by Geography
    • 12.8.1. Cell Therapy Consumables Market in North America, Till 2035
      • 12.8.1.1. Cell Therapy Consumables Market in the US, Till 2035
      • 12.8.1.2. Cell Therapy Consumables Market in Canada, Till 2035
      • 12.8.1.3. Cell Therapy Consumables Market in Rest of North America, Till 2035
    • 12.8.2. Cell Therapy Consumables Market in Europe, Till 2035
      • 12.8.2.1. Cell Therapy Consumables Market in Spain, Till 2035
      • 12.8.2.2. Cell Therapy Consumables Market in France, Till 2035
      • 12.8.2.3. Cell Therapy Consumables Market in Germany, Till 2035
      • 12.8.2.4. Cell Therapy Consumables Market in Italy, Till 2035
      • 12.8.2.5. Cell Therapy Consumables Market in the Netherlands, Till 2035
      • 12.8.2.6. Cell Therapy Consumables Market in the UK, Till 2035
      • 12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, Till 2035
    • 12.8.3. Cell Therapy Consumables Market in Asia-Pacific, Till 2035
      • 12.8.3.1. Cell Therapy Consumables Market in China, Till 2035
      • 12.8.3.2. Cell Therapy Consumables Market in Korea, Till 2035
      • 12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, Till 2035
    • 12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, Till 2035
    • 12.8.5. Cell Therapy Consumables Market in Latin America, Till 2035

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

  • 13.1. Chapter Overview
  • 13.2. Emerging Trends Related to Cell Culture Media
  • 13.3. Automation of Cell Therapy Manufacturing Processes
  • 13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS

  • 15.1. Chapter Overview
  • 15.2. Company A
    • 15.2.1. Interview Transcript: Vice President of Business Development - Cell Therapy
  • 15.3. Company B
    • 15.3.1. Interview Transcript: Chief Operating Officer
  • 15.4. Company C
    • 15.4.1. Interview Transcript: Director R&D, Cell Culture and Immunology and, Assistant R&D Manager, Animal Cell Culture

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 3.1 Cell Therapies: Applications
  • Table 3.2 Differences between Cell Therapies and Other Biopharmaceuticals
  • Table 3.3 Key Cell Therapy Manufacturing Steps
  • Table 3.4 Types of Media Used in Cell Therapy Manufacturing
  • Table 4.1 List of Cell Therapy Kit Providers
  • Table 4.2 Cell Therapy Kits: Information on Type of Cell Therapy and Type of Function
  • Table 4.3 Cell Therapy Kits: Information on Kit Components and Storage Temperature
  • Table 4.4 Cell Therapy Kits: Information on Scale of Operation and Application Area
  • Table 4.5 List of Cell Therapy Media Providers
  • Table 4.6 Cell Therapy Media: Information on Type of Cell Therapy, Media Compatibility and Type of Function
  • Table 4.7 Cell Therapy Media: Information on Storage Temperature and Volume of Media
  • Table 4.8 Cell Therapy Media: Information on Scale of Operation and Application Area
  • Table 4.9 List of Cell Therapy Reagent Providers
  • Table 4.10 Cell Therapy Reagents: Information on Type of Cell Therapy and Type of Function
  • Table 4.11 Cell Therapy Reagents: Information on Storage Temperature and Volume of Reagent
  • Table 4.12 Cell Therapy Reagents: Information on Scale of Operation and Application Area
  • Table 4.13 List of Cell Therapy Extracellular Matrix Providers
  • Table 4.14 Cell Therapy Extracellular Matrices: Information on Type of Stem Cell Therapy and Type of Function
  • Table 4.15 Cell Therapy Extracellular Matrices: Information on Type of ECM Coating and Type of Formulation
  • Table 4.16 Cell Therapy Extracellular Matrices: Information on Shelf Life, Storage Temperature and Volume of Extracellular Matrix
  • Table 4.17 Cell Therapy Extracellular Matrices: Information on Scale of Operation and Application Area
  • Table 7.1 STEMCELL Technologies: Company Overview
  • Table 7.2 STEMCELL Technologies: Recent Developments and Future Outlook
  • Table 7.3 Miltenyi Biotec: Company Overview
  • Table 7.4 Miltenyi Biotec: Recent Developments and Future Outlook
  • Table 7.5 Thermo Fisher Scientific: Company Overview
  • Table 7.6 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 7.7 Bio-Techne: Company Overview
  • Table 7.8 Bio-Techne: Recent Developments and Future Outlook
  • Table 7.9 Irvine Scientific: Company Overview
  • Table 7.10 Irvine Scientific: Recent Developments and Future Outlook
  • Table 7.11 Lonza: Company Overview
  • Table 7.12 Sartorius: Company Overview
  • Table 7.13 Sartorius: Recent Developments and Future Outlook
  • Table 7.14 BD Biosciences: Company Overview
  • Table 7.15 BD Biosciences: Recent Developments and Future Outlook
  • Table 7.16 Corning: Company Overview
  • Table 7.17 CellGenix: Company Overview
  • Table 7.18 CellGenix: Recent Developments and Future Outlook
  • Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, Since 2015
  • Table 8.2 Cell Therapy Consumables: Information on Location of Headquarters, 2015 Onwards
  • Table 8.3 Mergers and Acquisitions: List of Mergers and Acquisitions, 2016 Onwards
  • Table 8.4 Mergers and Acquisitions: Information on Key Value Drivers, 2016 Onwards
  • Table 8.5 Cell Therapy Consumables: List of Recent Expansions, 2017 Onwards
  • Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
  • Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
  • Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
  • Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
  • Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
  • Table 10.1 Media Price Evaluation Matrix: Based on Volume of Media
  • Table 10.2 Media Price Evaluation Matrix: Based on Media Compatibility
  • Table 10.3 Media Price Evaluation Matrix: Based on Type of Product Manufacturing Practices
  • Table 10.4 Media Price Evaluation Matrix: Based on Application Area
  • Table 10.5 Media Price Evaluation Matrix: Based on Storage Temperature
  • Table 10.6 Media Price Evaluation Matrix: Based on Type of Cell Therapy
  • Table 10.7 Media Price Evaluation Matrix: Based on Type of Function
  • Table 10.8 ECM Price Evaluation Matrix: Based on Type of ECM Coating
  • Table 10.9 ECM Price Evaluation Matrix: Based on Type of Formulation
  • Table 10.10 ECM Price Evaluation Matrix: Based on Volume of Extracellular Matrix
  • Table 10.11 ECM Price Evaluation Matrix: Based on Storage Temperature
  • Table 10.12 ECM Price Evaluation Matrix: Based on Shelf Life
  • Table 10.13 ECM Price Evaluation Matrix: Based on Type of Stem Cell Therapy
  • Table 10.14 ECM Price Evaluation Matrix: Based on Type of Function
  • Table 15.1 Akadeum Life Sciences: Key Highlights
  • Table 15.2 Cellular Engineering Technologies: Key Highlights
  • Table 15.3 HiMedia Laboratories: Key Highlights
  • Table 16.1 Cell Therapy Consumables: Distribution by Type of Product
  • Table 16.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
  • Table 16.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
  • Table 16.4 Cell Therapy Kit Providers: Distribution by Company Size
  • Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
  • Table 16.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
  • Table 16.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
  • Table 16.8 Cell Therapy Kit Providers: Distribution by Type of End-User
  • Table 16.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
  • Table 16.10 Cell Therapy Kits: Distribution by Type of Function
  • Table 16.11 Cell Therapy Kits: Distribution by Kit Components
  • Table 16.12 Cell Therapy Kits: Distribution by Storage Temperature
  • Table 16.13 Cell Therapy Kits: Distribution by Scale of Operation
  • Table 16.14 Cell Therapy Kits: Distribution by Application Area
  • Table 16.15 Cell Therapy Media Providers: Distribution by Year of Establishment
  • Table 16.16 Cell Therapy Media Providers: Distribution by Company Size
  • Table 16.17 Cell Therapy Media Providers: Distribution by Location of Headquarters
  • Table 16.18 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
  • Table 16.19 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
  • Table 16.20 Cell Therapy Media Providers: Distribution by Type of End-User
  • Table 16.21 Cell Therapy Media: Distribution by Type of Cell Therapy
  • Table 16.22 Cell Therapy Media: Distribution by Media Compatibility
  • Table 16.23 Cell Therapy Media: Distribution by Type of Function
  • Table 16.24 Cell Therapy Media: Distribution by Storage Temperature
  • Table 16.25 Cell Therapy Media: Distribution by Volume of Media
  • Table 16.26 Cell Therapy Media: Distribution by Scale of Operation
  • Table 16.27 Cell Therapy Media: Distribution by Application Area
  • Table 16.28 Cell Therapy Reagent Providers: Distribution by Year of Establishment
  • Table 16.29 Cell Therapy Reagent Providers: Distribution by Company Size
  • Table 16.30 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
  • Table 16.31 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
  • Table 16.32 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
  • Table 16.33 Cell Therapy Reagent Providers: Distribution by Type of End-User
  • Table 16.34 Cell Therapy Reagents: Distribution by Type of Cell Therapy
  • Table 16.35 Cell Therapy Reagents: Distribution by Type of Function
  • Table 16.36 Cell Therapy Reagents: Distribution by Storage Temperature
  • Table 16.37 Cell Therapy Reagents: Distribution by Volume of Reagent
  • Table 16.38 Cell Therapy Reagents: Distribution by Scale of Operation
  • Table 16.39 Cell Therapy Reagents: Distribution by Application Area
  • Table 16.40 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
  • Table 16.41 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
  • Table 16.42 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
  • Table 16.43 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
  • Table 16.44 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
  • Table 16.45 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
  • Table 16.46 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
  • Table 16.47 Cell Therapy Extracellular Matrices: Distribution by Type of Function
  • Table 16.48 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
  • Table 16.49 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
  • Table 16.50 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
  • Table 16.51 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
  • Table 16.52 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
  • Table 16.53 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
  • Table 16.54 Cell Therapy Extracellular Matrices: Distribution by Application Area
  • Table 16.55 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015 Onwards
  • Table 16.56 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 16.57 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership, 2015 Onwards
  • Table 16.58 Partnerships and Collaborations: Distribution by Type of Product
  • Table 16.59 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
  • Table 16.60 Partnerships and Collaborations: Distribution by Type of Cell Therapy
  • Table 16.61Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
  • Table 16.62 Most Active Players: Distribution by Number of Partnerships
  • Table 16.63 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 16.64 Partnerships and Collaborations: Local and International Agreements
  • Table 16.65 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016 Onwards
  • Table 16.66 Mergers and Acquisitions: Distribution by Type of Agreement
  • Table 16.67 Mergers and Acquisitions: Distribution by Key Value Drivers
  • Table 16.68 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers, 2016 Onwards
  • Table 16.69 Recent Expansions: Cumulative Year-wise Trend, 2017 Onwards
  • Table 16.70 Recent Expansions: Distribution by Type of Expansion
  • Table 16.71 Recent Expansions: Distribution by Year and Type of Expansion, 2017 Onwards
  • Table 16.72 Recent Expansions: Distribution by Type of Product
  • Table 16.73 Recent Expansions: Distribution by Type of Expansion and Type of Product
  • Table 16.74 Recent Expansions: Distribution by Area of Expansion
  • Table 16.75 Most Active Players: Distribution by Number of Expansions
  • Table 16.76 Recent Expansions: Distribution by Location of Facility (Continent-wise)
  • Table 16.77 Recent Expansions: Distribution by Location of Facility (Country-wise)
  • Table 16.78 Recent Expansions: Distribution by Type of Expansion and Location of Facility
  • Table 16.79 Global Demand for Cell Therapy Consumables, Till 2035 (Thousand Liters)
  • Table 16.80 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035 (Thousand Liters)
  • Table 16.81 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035 (Thousand Liters)
  • Table 16.82 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035: Distribution by Scale of Operation (Thousand Liters)
  • Table 16.83 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035: Distribution by Scale of Operation (Thousand Liters)
  • Table 16.84 Global Demand for Cell Therapy Consumables: Distribution by Geography, Current Year and 2035
  • Table 16.85 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035: Distribution by Geography (Thousand Liters)
  • Table 16.86 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035: Distribution by Geography (Thousand Liters)
  • Table 16.87 Global Cell Therapy Consumables Market, Till 2035 (USD Million)
  • Table 16.88 Cell Therapy Consumables Market: Distribution by Type of Product, Current Year and 2035
  • Table 16.89 Cell Therapy Consumables Market for Extracellular Matrices, Till 2035 (USD Million)
  • Table 16.90 Cell Therapy Consumables Market for Kits, Till 2035 (USD Million)
  • Table 16.91 Cell Therapy Consumables Market for Media, Till 2035 (USD Million)
  • Table 16.92 Cell Therapy Consumables Market for Reagents, Till 2035 (USD Million)
  • Table 16.93 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
  • Table 16.94 Cell Therapy Consumables Market for Dendritic Cell Therapies, Till 2035 (USD Million)
  • Table 16.95 Cell Therapy Consumables Market for NK Cell Therapies, Till 2035 (USD Million)
  • Table 16.96 Cell Therapy Consumables Market for Stem Cell Therapies, Till 2035 (USD Million)
  • Table 16.97 Cell Therapy Consumables Market for T-Cell Therapies, Till 2035 (USD Million)
  • Table 16.98 Cell Therapy Consumables Market: Distribution by Scale of Operation, Current Year and 2035
  • Table 16.99 Cell Therapy Consumables Market for Clinical Operations, Till 2035 (USD Million)
  • Table 16.100 Cell Therapy Consumables Market for Commercial Operations, Till 2035 (USD Million)
  • Table 16.101 Cell Therapy Consumables Market: Distribution by Type of End-User, Current Year and 2035
  • Table 16.102 Cell Therapy Consumables Market for Industry Players, Till 2035 (USD Million)
  • Table 16.103 Cell Therapy Consumables Market for Non-Industry Players, Till 2035 (USD Million)
  • Table 16.104 Cell Therapy Consumables Market: Distribution by Geography, Current Year and 2035
  • Table 16.105 Cell Therapy Consumables Market in North America, Till 2035 (USD Million)
  • Table 16.106 Cell Therapy Consumables Market in the US, Till 2035 (USD Million)
  • Table 16.107 Cell Therapy Consumables Market in Canada, Till 2035 (USD Million)
  • Table 16.108 Cell Therapy Consumables Market in Rest of North America, Till 2035 (USD Million)
  • Table 16.109 Cell Therapy Consumables Market in Europe, Till 2035 (USD Million)
  • Table 16.110 Cell Therapy Consumables Market in Spain, Till 2035 (USD Million)
  • Table 16.111 Cell Therapy Consumables Market in France, Till 2035 (USD Million)
  • Table 16.112 Cell Therapy Consumables Market in Germany, Till 2035 (USD Million)
  • Table 16.113 Cell Therapy Consumables Market in Italy, Till 2035 (USD Million)
  • Table 16.114 Cell Therapy Consumables Market in the Netherlands, Till 2035 (USD Million)
  • Table 16.115 Cell Therapy Consumables Market in the UK, Till 2035 (USD Million)
  • Table 16.116 Cell Therapy Consumables Market in Rest of Europe, Till 2035 (USD Million)
  • Table 16.117 Cell Therapy Consumables Market in Asia-Pacific, Till 2035 (USD Million)
  • Table 16.118 Cell Therapy Consumables Market in China, Till 2035 (USD Million)
  • Table 16.119 Cell Therapy Consumables Market in Korea, Till 2035 (USD Million)
  • Table 16.120 Cell Therapy Consumables Market in Rest of Asia-Pacific, Till 2035 (USD Million)
  • Table 16.121 Cell Therapy Consumables Market in Middle East and North Africa, Till 2035 (USD Million)
  • Table 16.122 Cell Therapy Consumables Market in Latin America, Till 2035 (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Market Landscape
  • Figure 2.2 Executive Summary: Recent Developments and Initiatives
  • Figure 2.3 Executive Summary: Demand Analysis
  • Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Types of Cell Therapy Consumables
  • Figure 4.1 Cell Therapy Consumables: Distribution by Type of Product
  • Figure 4.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
  • Figure 4.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
  • Figure 4.4 Cell Therapy Kit Providers: Distribution by Company Size
  • Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
  • Figure 4.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
  • Figure 4.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
  • Figure 4.8 Cell Therapy Kit Providers: Distribution by Type of End-User
  • Figure 4.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
  • Figure 4.10 Cell Therapy Kits: Distribution by Type of Function
  • Figure 4.11 Cell Therapy Kits: Distribution by Kit Components
  • Figure 4.12 Cell Therapy Kits: Distribution by Storage Temperature
  • Figure 4.13 Cell Therapy Kits: Distribution by Scale of Operation
  • Figure 4.14 Cell Therapy Kits: Distribution by Application Area
  • Figure 4.15 Cell Therapy Kit Providers: Distribution by Application Area and Geography
  • Figure 4.16 Cell Therapy Media Providers: Distribution by Year of Establishment
  • Figure 4.17 Cell Therapy Media Providers: Distribution by Company Size
  • Figure 4.18 Cell Therapy Media Providers: Distribution by Location of Headquarters
  • Figure 4.19 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
  • Figure 4.20 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
  • Figure 4.21 Cell Therapy Media Providers: Distribution by Type of End-User
  • Figure 4.22 Cell Therapy Media: Distribution by Type of Cell Therapy
  • Figure 4.23 Cell Therapy Media: Distribution by Media Compatibility
  • Figure 4.24 Cell Therapy Media: Distribution by Type of Function
  • Figure 4.25 Cell Therapy Media: Distribution by Storage Temperature
  • Figure 4.26 Cell Therapy Media: Distribution by Volume of Media
  • Figure 4.27 Cell Therapy Media: Distribution by Scale of Operation
  • Figure 4.28 Cell Therapy Media: Distribution by Application Area
  • Figure 4.29 Cell Therapy Media Providers: Distribution by Application Area and Geography
  • Figure 4.30 Cell Therapy Reagent Providers: Distribution by Year of Establishment
  • Figure 4.31 Cell Therapy Reagent Providers: Distribution by Company Size
  • Figure 4.32 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
  • Figure 4.33 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
  • Figure 4.34 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
  • Figure 4.35 Cell Therapy Reagent Providers: Distribution by Type of End-User
  • Figure 4.36 Cell Therapy Reagents: Distribution by Type of Cell Therapy
  • Figure 4.37 Cell Therapy Reagents: Distribution by Type of Function
  • Figure 4.38 Cell Therapy Reagents: Distribution by Storage Temperature
  • Figure 4.39 Cell Therapy Reagents: Distribution by Volume of Reagent
  • Figure 4.40 Cell Therapy Reagents: Distribution by Scale of Operation
  • Figure 4.41 Cell Therapy Reagents: Distribution by Application Area
  • Figure 4.42 Cell Therapy Reagent Providers: Distribution by Application Area and Geography
  • Figure 4.43 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
  • Figure 4.44 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
  • Figure 4.45 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
  • Figure 4.46 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
  • Figure 4.47 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
  • Figure 4.48 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
  • Figure 4.49 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
  • Figure 4.50 Cell Therapy Extracellular Matrices: Distribution by Type of Function
  • Figure 4.51 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
  • Figure 4.52 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
  • Figure 4.53 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
  • Figure 4.54 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
  • Figure 4.55 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrices
  • Figure 4.56 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
  • Figure 4.57 Cell Therapy Extracellular Matrices: Distribution by Application Area
  • Figure 4.58 Cell Therapy Extracellular Matrix Providers: Distribution by Application Area and Geography
  • Figure 5.1 Company Competitiveness Analysis: Cell Therapy Kit Providers
  • Figure 5.2 Company Competitiveness Analysis: Cell Therapy Media Providers based in North America
  • Figure 5.3 Company Competitiveness Analysis: Cell Therapy Media Providers based in Europe
  • Figure 5.4 Company Competitiveness Analysis: Cell Therapy Media Providers based in Asia-Pacific
  • Figure 5.5 Company Competitiveness Analysis: Cell Therapy Reagent Providers
  • Figure 5.6 Company Competitiveness Analysis: Cell Therapy Extracellular Matrix Providers
  • Figure 6.1 Brand Positioning Matrix: STEMCELL Technologies
  • Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec
  • Figure 6.3 Brand Positioning Matrix: Thermo Fisher Scientific
  • Figure 6.4 Brand Positioning Matrix: Takara Bio
  • Figure 6.5 Brand Positioning Matrix: GeminiBio
  • Figure 7.1 STEMCELL Technologies: Product Portfolio
  • Figure 7.2 Miltenyi Biotec: Product Portfolio
  • Figure 7.3 Thermo Fisher Scientific: Product Portfolio
  • Figure 7.4 Bio-Techne: Product Portfolio
  • Figure 7.5 Irvine Scientific: Product Portfolio
  • Figure 7.6 Lonza: Product Portfolio
  • Figure 7.7 Sartorius: Product Portfolio
  • Figure 7.8 BD Biosciences: Product Portfolio
  • Figure 7.9 Corning: Product Portfolio
  • Figure 7.10 CellGenix: Product Portfolio
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2015
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
  • Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
  • Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
  • Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
  • Figure 8.8 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 8.10 Partnerships and Collaborations: Local and International Agreements
  • Figure 8.11 Mergers and Acquisitions: Cumulative Year-wise Trend, Since 2016
  • Figure 8.12 Mergers and Acquisitions: Distribution by Type of Agreement
  • Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
  • Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
  • Figure 8.15 Recent Expansions: Cumulative Year-wise Trend, 2017 Onwards
  • Figure 8.16 Recent Expansions: Distribution by Type of Expansion
  • Figure 8.17 Recent Expansions: Distribution by Year and Type of Expansion
  • Figure 8.18 Recent Expansions: Distribution by Type of Product
  • Figure 8.19 Recent Expansions: Distribution by Type of Expansion and Type of Product
  • Figure 8.20 Recent Expansions: Distribution by Area of Expansion (Sq. Ft.)
  • Figure 8.21 Most Active Players: Distribution by Number of Expansions
  • Figure 8.22 Recent Expansions: Distribution by Location of Facility (Continent-wise)
  • Figure 8.23 Recent Expansions: Distribution by Location of Facility (Country-wise)
  • Figure 8.24 Recent Expansions: Distribution by Type of Expansion and Location of Facility
  • Figure 10.1 Cell Therapy Media: Roots Analysis Pricing Strategy Matrix
  • Figure 10.2 Cell Therapy Media: Roots Analysis Pricing Strategy Graphical Interpretation
  • Figure 10.3 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Matrix
  • Figure 10.4 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Graphical Interpretation
  • Figure 11.1 Global Demand for Cell Therapy Consumables, Till 2035 (Thousand Liters)
  • Figure 11.2 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035 (Thousand Liters)
  • Figure 11.3 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035 (Thousand Liters)
  • Figure 11.4 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035: Distribution by Scale of Operation (Thousand Liters)
  • Figure 11.5 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035: Distribution by Scale of Operation (Thousand Lite
  • Figure 11.6 Global Demand for Cell Therapy Consumables: Distribution by Geography, Current Year and 2035
  • Figure 11.7 Global Demand for Cell Therapy Consumables for Planar Process, Till 2035: Distribution by Geography (Thousand Liters)
  • Figure 11.8 Global Demand for Cell Therapy Consumables for Suspension Process, Till 2035: Distribution by Geography (Thousand Liters)
  • Figure 12.1 Global Cell Therapy Consumables Market, Till 2035 (USD Million)
  • Figure 12.2 Cell Therapy Consumables Market: Distribution by Type of Product, Current Year and 2035
  • Figure 12.3 Cell Therapy Consumables Market for Extracellular Matrices, Till 2035 (USD Million)
  • Figure 12.4 Cell Therapy Consumables Market for Kits, Till 2035 (USD Million)
  • Figure 12.5 Cell Therapy Consumables Market for Media, Till 2035 (USD Million)
  • Figure 12.6 Cell Therapy Consumables Market for Reagents, Till 2035 (USD Million)
  • Figure 12.7 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
  • Figure 12.8 Cell Therapy Consumables Market for Dendritic Cell Therapies, Till 2035 (USD Million)
  • Figure 12.9 Cell Therapy Consumables Market for NK Cell Therapies, Till 2035 (USD Million)
  • Figure 12.10 Cell Therapy Consumables Market for Stem Cell Therapies, Till 2035 (USD Million)
  • Figure 12.11 Cell Therapy Consumables Market for T-Cell Therapies, Till 2035 (USD Million)
  • Figure 12.12 Cell Therapy Consumables Market: Distribution by Scale of Operation, Current Year and 2035
  • Figure 12.13 Cell Therapy Consumables Market for Clinical Operations, Till 2035 (USD Million)
  • Figure 12.14 Cell Therapy Consumables Market for Commercial Operations, Till 2035 (USD Million)
  • Figure 12.15 Cell Therapy Consumables Market: Distribution by Type of End-User, Current Year and 2035
  • Figure 12.16 Cell Therapy Consumables Market for Industry Players, Till 2035 (USD Million)
  • Figure 12.17 Cell Therapy Consumables Market for Non-Industry Players, Till 2035 (USD Million)
  • Figure 12.18 Cell Therapy Consumables Market: Distribution by Geography, Current Year and 2035
  • Figure 12.19 Cell Therapy Consumables Market in North America, Till 2035 (USD Million)
  • Figure 12.20 Cell Therapy Consumables Market in the US, Till 2035 (USD Million)
  • Figure 12.21 Cell Therapy Consumables Market in Canada, Till 2035 (USD Million)
  • Figure 12.22 Cell Therapy Consumables Market in Rest of North America, Till 2035 (USD Million)
  • Figure 12.23 Cell Therapy Consumables Market in Europe, Till 2035 (USD Million)
  • Figure 12.24 Cell Therapy Consumables Market in Spain, Till 2035 (USD Million)
  • Figure 12.25 Cell Therapy Consumables Market in France, Till 2035 (USD Million)
  • Figure 12.26 Cell Therapy Consumables Market in Germany, Till 2035 (USD Million)
  • Figure 12.27 Cell Therapy Consumables Market in Italy, Till 2035 (USD Million)
  • Figure 12.28 Cell Therapy Consumables Market in the Netherlands, Till 2035 (USD Million)
  • Figure 12.29 Cell Therapy Consumables Market in the UK, Till 2035 (USD Million)
  • Figure 12.30 Cell Therapy Consumables Market in Rest of Europe, Till 2035 (USD Million)
  • Figure 12.31 Cell Therapy Consumables Market in Asia-Pacific, Till 2035 (USD Million)
  • Figure 12.32 Cell Therapy Consumables Market in China, Till 2035 (USD Million)
  • Figure 12.33 Cell Therapy Consumables Market in Korea, Till 2035 (USD Million)
  • Figure 12.34 Cell Therapy Consumables Market in Rest of Asia-Pacific, Till 2035 (USD Million)
  • Figure 12.35 Cell Therapy Consumables Market in Middle East and North Africa, Till 2035 (USD Million)
  • Figure 12.36 Cell Therapy Consumables Market in Latin America, Till 2035 (USD Million)
  • Figure 14.1 Concluding Remarks: Overall Market Landscape
  • Figure 14.2 Concluding Remarks: Recent Developments
  • Figure 14.3 Concluding Remarks: Demand Analysis
  • Figure 14.4 Concluding Remarks: Market Forecast and Opportunity Analysis
  • Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis